Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.
Peptide A
Cognitive
Hepatocyte growth factor mimetic — claimed to be 7 orders of magnitude more potent than BDNF.
Peptide B
Cognitive
Neuroprotective tripeptide bioregulator that penetrates the nuclear membrane to directly regulate gene expression in brain tissue.
Typical vial
30 mg
Typical dose
8,000-45,000 (oral) mcg
Half-life
~3-4 hours (oral)
FDA status
Not FDA approved. The related HGF-positive modulator fosgoni…
Typical vial
20 mg
Typical dose
100-500 mcg
Half-life
~1-2 hours (estimated; formal pharmacokinetic data in humans is not published — biological effects on gene expression persist beyond plasma clearance)
FDA status
Not FDA approved. No IND or NDA has been submitted to the FD…
Dihexa effects
Pinealon effects
Dihexa side effects
Pinealon side effects
Dihexa dosing ranges
Cognitive research (oral / sublingual)
8-45 mg · Once daily · 30 days per cycle
Pinealon dosing ranges
Cognitive support and neuroprotection (subcutaneous)
100-500 mcg · Once daily · 10-20 days per cycle, repeated 2-4 times per year
Traumatic brain injury sequelae / cerebral asthenia (oral, clinical study protocol)
0.2 mg (200 mcg) twice daily · Twice daily · 20-30 days
General anti-aging and brain longevity (oral supplement)
10-20 mg per day (1-2 capsules of 10 mg each) · Once or twice daily, 30 minutes before meals · 1 month on, then reassess
Dihexa: Hepatocyte growth factor mimetic — claimed to be 7 orders of magnitude more potent than BDNF. Typical dose 8,000-45,000 (oral) mcg. Pinealon: Neuroprotective tripeptide bioregulator that penetrates the nuclear membrane to directly regulate gene expression in brain tissue. Typical dose 100-500 mcg. Both fall under the Cognitive category.
Stacking Dihexa with Pinealon is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.
Dihexa is typically dosed: Once daily for Cognitive research (oral / sublingual). Pinealon is typically dosed: Once daily for Cognitive support and neuroprotection (subcutaneous); Twice daily for Traumatic brain injury sequelae / cerebral asthenia (oral, clinical study protocol); Once or twice daily, 30 minutes before meals for General anti-aging and brain longevity (oral supplement).
Dihexa: Not FDA approved. The related HGF-positive modulator fosgonimeton (ATH-1017) is in clinical trials for Alzheimer's. Pinealon: Not FDA approved. No IND or NDA has been submitted to the FDA. Classified as a research chemical in the United States.
Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.
Get Started Free